BioCryst Pharmaceuticals Ownership | Who Owns BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals Ownership Summary
BioCryst Pharmaceuticals is owned by 84.55% institutional investors, 1.15% insiders, and 14.30% retail investors. Blackrock is the largest institutional shareholder, holding 9.68% of BCRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.17% of its assets in BioCryst Pharmaceuticals shares.
BCRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioCryst Pharmaceuticals | 84.55% | 1.15% | 14.30% |
| Sector | Healthcare Stocks | 46.98% | 7.90% | 45.12% |
| Industry | Biotech Stocks | 44.85% | 7.67% | 47.48% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 19.96M | 9.68% | $123.33M |
| Vanguard group | 18.77M | 9.11% | $116.00M |
| Avoro capital advisors | 12.57M | 6.10% | $77.68M |
| State street | 9.35M | 4.54% | $57.76M |
| Kynam capital management, lp | 8.83M | 4.28% | $54.55M |
| Deerfield management company, l.p. (series c) | 8.14M | 3.95% | $50.28M |
| Alkeon capital management | 7.10M | 3.45% | $43.87M |
| Geode capital management | 4.71M | 2.29% | $29.12M |
| Caligan partners lp | 4.60M | 2.23% | $28.42M |
| Nuveen asset management | 4.50M | 2.18% | $27.78M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rp management | 3.85M | 13.29% | $23.77M |
| Caligan partners lp | 4.60M | 6.64% | $28.42M |
| Kynam capital management, lp | 8.83M | 4.21% | $54.55M |
| Cutter capital management, lp | 1.98M | 3.68% | $12.21M |
| Oracle investment management | 535.56K | 3.09% | $3.31M |
| Alphacentric advisors | 675.00K | 3.07% | $4.17M |
| Sarissa capital management lp | 1.09M | 1.14% | $6.76M |
| Dafna capital management | 704.50K | 1.04% | $4.35M |
| Avoro capital advisors | 12.57M | 1.03% | $77.68M |
| Deerfield management company, l.p. (series c) | 8.14M | 0.84% | $50.28M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Caligan partners lp | 4.60M | 6.64% | 3.84M |
| Deerfield management company, l.p. (series c) | 8.14M | 0.84% | 3.14M |
| Alkeon capital management | 7.10M | 0.07% | 3.00M |
| Kynam capital management, lp | 8.83M | 4.21% | 2.30M |
| Nuveen asset management | 4.50M | 0.01% | 1.88M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | 75.78K | 0.01% | -10.05M |
| State street | 9.35M | 0.00% | -8.13M |
| Braidwell lp | - | - | -3.38M |
| Citigroup | 116.94K | 0.00% | -2.16M |
| Point72 asset management | - | - | -1.62M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 651.63K | 0.00% | 651.63K | $4.03M |
| Schonfeld strategic advisors | 452.60K | 0.02% | 452.60K | $2.80M |
| Parkman healthcare partners | 400.45K | 0.33% | 400.45K | $2.47M |
| Knott david m jr | 314.31K | 0.77% | 314.31K | $1.94M |
| Point72 europe (london) llp | 267.65K | 0.14% | 267.65K | $1.65M |
Sold Out
| Holder | Change |
|---|---|
| Tfo-tdc | -3.00 |
| Financial gravity asset management | -8.00 |
| Dinuzzo private wealth | -13.00 |
| Newbridge financial services group | -15.00 |
| Sjs investment consulting | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 246 | -1.99% | 174,231,087 | -2.64% | 84 | 1.12% | 125 | 7.76% | 67 | -4.29% |
| Mar 31, 2024 | 251 | 1.62% | 178,960,740 | 1.28% | 86 | 1.03% | 116 | 3.57% | 70 | -10.26% |
| Dec 31, 2023 | 247 | 1.65% | 176,694,388 | 1.14% | 91 | 1.08% | 112 | -7.44% | 78 | 34.48% |
| Sep 30, 2023 | 243 | -2.41% | 174,701,852 | 0.47% | 92 | 1.09% | 121 | -1.63% | 58 | -1.69% |
| Jun 30, 2023 | 249 | -3.49% | 173,890,981 | 1.99% | 91 | 1.12% | 123 | -6.82% | 59 | -18.06% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 6.57M | 3.17% | -18.55K |
| iShares Russell 2000 ETF | 5.29M | 2.56% | -11.90K |
| SPDR® S&P Biotech ETF | 4.09M | 1.98% | 45.28K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.14M | 1.52% | 43.66K |
| Vanguard Small Cap Index | 2.59M | 1.25% | -13.97K |
| CREF Stock R1 | 2.29M | 1.11% | - |
| Fidelity Small Cap Index | 2.11M | 1.02% | -52.02K |
| iShares Russell 2000 Growth ETF | 1.85M | 0.89% | - |
| Fidelity Select Biotechnology | 1.79M | 0.86% | - |
| Vanguard Strategic Equity Inv | 1.52M | 0.73% | 514.93K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 24, 2024 | McKee Amy E | - | Sell | $54.35K |
| Jun 17, 2024 | SANDERS MACHELLE | - | Sell | $28.13K |
| Jun 14, 2024 | HEGGIE THERESA | - | Sell | $40.92K |
| May 30, 2024 | LEVIN ALAN G | - | Buy | $50.00K |
| May 24, 2024 | ASELAGE STEVE | - | Buy | $16.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q2 | 10 | 3 |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | - | - |
| 2023 Q2 | - | 3 |
BCRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools